-
-
L611543-25mglirafugratinib.
-
L611543-5mglirafugratinib.
-
L611545-25mglisinopril-tryptophan.
-
L611545-5mglisinopril-tryptophan.
-
-
-
L414198-100mgInformationLIT-927 is a novel neutraligand ofCXCL12with Ki value of 267 nM for inhibition of Texas red-labeled CXCL12 (CXCL12-TR) binding. It shows high selectivity toward CXCL12 vs other chemokines also involved in asthma.TargetsCXCR4 : CXCL12 :
-
L414198-10mgInformationLIT-927 is a novel neutraligand ofCXCL12with Ki value of 267 nM for inhibition of Texas red-labeled CXCL12 (CXCL12-TR) binding. It shows high selectivity toward CXCL12 vs other chemokines also involved in asthma.TargetsCXCR4 : CXCL12 :
-
L414198-25mgInformationLIT-927 is a novel neutraligand ofCXCL12with Ki value of 267 nM for inhibition of Texas red-labeled CXCL12 (CXCL12-TR) binding. It shows high selectivity toward CXCL12 vs other chemokines also involved in asthma.TargetsCXCR4 : CXCL12 :
-
L414198-50mgInformationLIT-927 is a novel neutraligand ofCXCL12with Ki value of 267 nM for inhibition of Texas red-labeled CXCL12 (CXCL12-TR) binding. It shows high selectivity toward CXCL12 vs other chemokines also involved in asthma.TargetsCXCR4 : CXCL12 :
-
L414198-5mgInformationLIT-927 is a novel neutraligand ofCXCL12with Ki value of 267 nM for inhibition of Texas red-labeled CXCL12 (CXCL12-TR) binding. It shows high selectivity toward CXCL12 vs other chemokines also involved in asthma.TargetsCXCR4 : CXCL12 :